The Dublin-based company said it had net income of 82 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were $1.62 per share.

The results topped Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $1.58 per share.

The medical device company posted revenue of $8.93 billion in the period, which also beat Street forecasts. Ten analysts surveyed by Zacks expected $8.83 billion.

For the year, the company reported profit of $4.66 billion, or $3.61 per share. Revenue was reported as $33.54 billion.

Medtronic expects full-year earnings in the range of $5.50 to $5.60 per share.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MDT at https://www.zacks.com/ap/MDT